FDA Plans Public Meeting On Pediatric Drug Research, Labeling Issues

By Donna Haseley / October 24, 2019 at 4:08 PM
FDA will gather advice from stakeholders on whether pediatric research and labeling policies need to be revamped at a public meeting Nov. 21. The agency will use the input to draft a report updating Congress on its implementation of the Best Pharmaceuticals for Children Act (BPCA) and Pediatric Research Equity Act (PREA), FDA explained in a Federal Register notice Thursday (Oct. 24). FDA hopes to learn how the two pediatric laws have affected patients, industry, academia and other stakeholders...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.